(Q51480420)

5 April 2018

title

Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. (English)

1 reference

5 April 2018

1 reference

Haider DG

1

1 reference

5 April 2018

Schindler K

2

1 reference

5 April 2018

Mittermayer F

3

1 reference

5 April 2018

Müller M

4

1 reference

5 April 2018

Nowotny P

5

1 reference

5 April 2018

Rieger A

6

1 reference

5 April 2018

Luger A

7

1 reference

5 April 2018

Ludvik B

8

1 reference

5 April 2018

Wolzt M

9

1 reference

5 April 2018

language of work or name

English

0 references

publication date

18 January 2007

1 reference

5 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

5 April 2018

volume

81

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

580-585

1 reference

5 April 2018

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: a potential mechanism for hyperinsulinaemia-associated leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Retinol, alpha-tocopherol and carotenoids in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Peroxisome proliferator-activated receptors: from genes to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

7 January 2021

Free fatty acids normalize a rosiglitazone-induced visfatin release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

7 January 2021

Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

7 January 2021

Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100047

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100047

1 reference

5 April 2018

PubMed ID

17235334

1 reference

5 April 2018